3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Colorectal Neoplasms
17
Colonic Neoplasms
15
Rectal Neoplasms
11
Stomach Neoplasms
10
Ovarian Neoplasms
6
Neoplasms
5
Gastrointestinal Stromal Tumors
5
Carcinoma, Hepatocellular
5
Uterine Cervical Neoplasms
3
Pancreatic Neoplasms
3
Liver Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Prostatic Neoplasms
2
Peritoneal Neoplasms
2
Neoplastic Cells, Circulating
2
Kidney Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Venous Thrombosis
1
Uterine Neoplasms
1
Surgical Wound Infection
1
Robotic
1
Polycystic Ovary Syndrome
1
Pancreatic Neuroendocrine Tumors
1
Ornithine Carbamoyltransferase Deficiency Disease
1
Obesity, Morbid
1
Neurologic Manifestations
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Interventions
Carboplatin
75
Paclitaxel
68
Bevacizumab
44
Taxes
22
Cyclophosphamide
21
pembrolizumab
19
Gemcitabine
19
Cisplatin
18
Topotecan
17
Hyperthermic Intraperitoneal Chemotherapy
14
olaparib
13
liposomal doxorubicin
13
Immunoglobulin G
13
Disulfides
13
Specimen Handling
11
Drug Therapy
11
niraparib
10
Cytoreduction Surgical Procedures
10
Magnetic Resonance Spectroscopy
9
sargramostim
7
Surveys and Questionnaires
7
Doxorubicin
7
Docetaxel
7
durvalumab
6
Platinum
6
Nivolumab
6
Letrozole
6
Granulocyte-Macrophage Colony-Stimulating Factor
6
Biopsy
6
Albumin-Bound Paclitaxel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Fallopian Tube Neoplasms
×
Laparoscopy
×
Clear all
NCT03378128
2022-03-14
MIID-SOC
Case Comprehensive Cancer Center
Phase NA
Completed
50 enrolled